Sonoma Pharmaceuticals, Inc. Made Headway
Tue, May 03, 2022 at 05:35 PM
Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ) shot up at $3.5, representing a gain of 31.6%. On Mon, May 02, 2022, SNOA:NASDAQ touched a New 2-Week Intraday Low of $2.59. The stock appeared on our News Catalysts scanner on Tue, May 03, 2022 at 02:19 PM in the 'MISCELLANEOUS' category. From Mon, Apr 18, 2022, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Mar 30, 2022 at $4.14 with a volume of 5M+.
About Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ)
Sonoma Pharmaceuticals Inc is a speciality pharmaceutical company. It develops,identifies and commercialises therapies for dermatologic diseases.
Top 10 Gainers:
- Blue Water Vaccines Inc. (BWV:NASDAQ), 93.11%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 59.13%
- Ostin Technology Group Co. Ltd. (OST:NASDAQ), 57.28%
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 54%
- Titan Medical Inc. (TMDI:NASDAQ), 32.7%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 31.58%
- Belite Bio Inc (BLTE:NASDAQ), 30.78%
- Sesen Bio, Inc. (SESN:NASDAQ), 29.97%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 28.23%
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 25.24%